View Financial HealthMapath Capital 배당 및 자사주 매입배당 기준 점검 0/6Mapath Capital 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Oct 28Mapath Capital Corp. announced that it expects to receive CAD 1 million in fundingMapath Capital Corp. announced a non-brokered private placement of up to 20,000,000 common shares in the capital of the company at a price of CAD 0.05 per offered share for gross proceeds of up to CAD 1,000,000 on October 27, 2025. There are no finders' fees in connection with the offering. All securities to be issued pursuant to the offering and shares for debt will be subject to a regulatory hold period of four months and a day in accordance with the rules and policies of the TSX Venture Exchange, applicable Canadian securities laws, and such other further restrictions as may apply. Upon TSX-V acceptance, the company will close the offering. Two insiders of the company expect to purchase an aggregate of 800,000 offered shares in the offering and will receive the 568,000 common shares pursuant to the shares for debt.공시 • Oct 15Mapath Capital Corp., Annual General Meeting, Dec 11, 2024Mapath Capital Corp., Annual General Meeting, Dec 11, 2024.공시 • Sep 27Mapath Capital Corp., Annual General Meeting, Nov 16, 2023Mapath Capital Corp., Annual General Meeting, Nov 16, 2023.공시 • Sep 12Mapath Capital Corp. announced that it has received CAD 0.1 million in fundingOn September 11, 2023, Mapath Capital Corp. closed the transaction. The debentures and any units acquired on conversion thereof are subject to a hold period expiring on Jan. 9, 2024. No finders fees were paid in connection with the financing. Insiders of the company were issued debentures with a principal amount in aggregate of CAD 100,000. Pursuant to the financing, ROI Capital Inc., acquired a debenture of the company in the aggregate principal amount of CAD 68,000 which is convertible into 1.36 million common shares and 1.36 million warrants if converted in the first year of its term, or 680,000 common shares if converted in the second year of its term. In addition to the debenture, New, directly and indirectly, owns and/or controls, in aggregate 12,854,000 common shares, representing 49.20 per cent of the current issued and outstanding common shares. Following the completion of the financing and assuming conversion of the debenture during the first year of its term, New would own and/or control, directly and indirectly, or have control or direction over, an aggregate of 15,574,000 shares of the company, representing 51.70 per cent of the issued and outstanding common shares of the company on a diluted basis. Following the completion of the financing and assuming conversion of the debenture during the second year of its term, New would own and/or control, directly and indirectly, or have control or direction over, an aggregate of 13,534,000 shares of the company, representing 49.90 per cent of the issued and outstanding common shares of the company on a diluted basis.공시 • Jul 26Mapath Capital Corp. announced that it expects to receive CAD 0.1 million in fundingMapath Capital Corp. announced a non-brokered private placement to issue 10% Convertible notes for the gross proceeds of CAD 100,000 on July 25, 2023. The Notes will bear interest at the rate of 10% per annum with a 24-month term and are convertible during the Term at the option of the holder to acquire units at a price of CAD 0.04 per Unit for a period of one year from the issuance of the Notes and one common share of the Company at a price of CAD 0.04 per share for a period of one year thereafter, all subject to Exchange approval. Upon conversion in the first year, each Unit will consist of one common share of the Company and one common share purchase warrant. Each Warrant will entitle the holder to acquire one additional common share of the Company at a price of CAD 0.05 per common share for a period of one year from the issuance of the Notes. The transaction will include participation from an insider. All securities issued in connection with the Offering will be subject to a statutory and Exchange hold period of four months and a day commencing from the date of issuance. The closing of the Offering is subject to regulatory approval, including Exchange acceptance.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 IVFZ.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: IVFZ.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Mapath Capital 배당 수익률 vs 시장IVFZ.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (IVFZ.F)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Professional Services)2.6%분석가 예측 (IVFZ.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 IVFZ.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 IVFZ.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 IVFZ.F 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: IVFZ.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/03/28 22:20종가2025/12/29 00:00수익2025/09/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Mapath Capital Corp.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Siddharth RajeevFundamental Research Corp.
공시 • Oct 28Mapath Capital Corp. announced that it expects to receive CAD 1 million in fundingMapath Capital Corp. announced a non-brokered private placement of up to 20,000,000 common shares in the capital of the company at a price of CAD 0.05 per offered share for gross proceeds of up to CAD 1,000,000 on October 27, 2025. There are no finders' fees in connection with the offering. All securities to be issued pursuant to the offering and shares for debt will be subject to a regulatory hold period of four months and a day in accordance with the rules and policies of the TSX Venture Exchange, applicable Canadian securities laws, and such other further restrictions as may apply. Upon TSX-V acceptance, the company will close the offering. Two insiders of the company expect to purchase an aggregate of 800,000 offered shares in the offering and will receive the 568,000 common shares pursuant to the shares for debt.
공시 • Oct 15Mapath Capital Corp., Annual General Meeting, Dec 11, 2024Mapath Capital Corp., Annual General Meeting, Dec 11, 2024.
공시 • Sep 27Mapath Capital Corp., Annual General Meeting, Nov 16, 2023Mapath Capital Corp., Annual General Meeting, Nov 16, 2023.
공시 • Sep 12Mapath Capital Corp. announced that it has received CAD 0.1 million in fundingOn September 11, 2023, Mapath Capital Corp. closed the transaction. The debentures and any units acquired on conversion thereof are subject to a hold period expiring on Jan. 9, 2024. No finders fees were paid in connection with the financing. Insiders of the company were issued debentures with a principal amount in aggregate of CAD 100,000. Pursuant to the financing, ROI Capital Inc., acquired a debenture of the company in the aggregate principal amount of CAD 68,000 which is convertible into 1.36 million common shares and 1.36 million warrants if converted in the first year of its term, or 680,000 common shares if converted in the second year of its term. In addition to the debenture, New, directly and indirectly, owns and/or controls, in aggregate 12,854,000 common shares, representing 49.20 per cent of the current issued and outstanding common shares. Following the completion of the financing and assuming conversion of the debenture during the first year of its term, New would own and/or control, directly and indirectly, or have control or direction over, an aggregate of 15,574,000 shares of the company, representing 51.70 per cent of the issued and outstanding common shares of the company on a diluted basis. Following the completion of the financing and assuming conversion of the debenture during the second year of its term, New would own and/or control, directly and indirectly, or have control or direction over, an aggregate of 13,534,000 shares of the company, representing 49.90 per cent of the issued and outstanding common shares of the company on a diluted basis.
공시 • Jul 26Mapath Capital Corp. announced that it expects to receive CAD 0.1 million in fundingMapath Capital Corp. announced a non-brokered private placement to issue 10% Convertible notes for the gross proceeds of CAD 100,000 on July 25, 2023. The Notes will bear interest at the rate of 10% per annum with a 24-month term and are convertible during the Term at the option of the holder to acquire units at a price of CAD 0.04 per Unit for a period of one year from the issuance of the Notes and one common share of the Company at a price of CAD 0.04 per share for a period of one year thereafter, all subject to Exchange approval. Upon conversion in the first year, each Unit will consist of one common share of the Company and one common share purchase warrant. Each Warrant will entitle the holder to acquire one additional common share of the Company at a price of CAD 0.05 per common share for a period of one year from the issuance of the Notes. The transaction will include participation from an insider. All securities issued in connection with the Offering will be subject to a statutory and Exchange hold period of four months and a day commencing from the date of issuance. The closing of the Offering is subject to regulatory approval, including Exchange acceptance.